Updated Jul 16, 2026 · Last SEC filing 2026-07-07
ORAGENICS INC (OGEN) has filed 1 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-07. 3 Form 8-K material event filings were reported by OGEN in the last 90 days. InsiderAlpha tracks every OGEN SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001174940 |
|---|
| Form 4 filings (90d) | 1 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Latest Form 4 filing | 2026-07-07 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Telling Fred | Director | S — Open-market sale | 210 | $0.94 | $198 | SEC | |
| Odyssey Health, Inc. | 10% Owner | S — Open-market sale | 5.0K | $4.26 | $21K | SEC | |
| Odyssey Health, Inc. | 10% Owner | S — Open-market sale | 2.0K | $4.46 | $9K | SEC | |
| Odyssey Health, Inc. | 10% Owner | S — Open-market sale | 5.0K | $4.45 | $22K | SEC | |
| Odyssey Health, Inc. | 10% Owner | S — Open-market sale | 5.0K | $4.27 | $21K | SEC | |
| KOSKI ROBERT C | Director | J — Other acquisition / disposition | 5.0K | — | — | SEC | |
| Telling Fred | Director | S — Open-market sale | 3.6K | $0.36 | $1K | SEC | |
| DUNTON ALAN W | Director | S — Open-market sale | 66 | $0.36 | $24 | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for ORAGENICS INC (OGEN). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Spencer John | 1 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in OGEN insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live OGEN dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.